Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic indexJagath R. Junutula, William Mallet, Siao Ping Tsai et al.|Nature Biotechnology|2008Cited by 1.4k
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugatesBen‐Quan Shen, Jagath R. Junutula, Keyang Xu et al.|Nature Biotechnology|2012Cited by 997
An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody–Drug Conjugate for the Treatment of Hormone Receptor–Positive Breast CancerSunil Bhakta, Jagath R. Junutula|Molecular Cancer Therapeutics|2017Cited by 31
An improved and robust DNA immunization method to develop antibodies against extra-cellular loops of multi-transmembrane proteinsMeredith Hazen, Jo-Anne Hongo, Sunil Bhakta et al.|mAbs|2013Cited by 28